Summary
Subject attrition from randomized Schizophrenia trials is a significant problem and has been found in a meta-analysis to be as high as 76%. The problem of drop-out is sometimes not addressed until the statistical analysis stage of a study which can decrease the validity of the results increasing the likelihood of a failed trial. The authors previously examined the effect of 9 trial design variables on individual completion in 11 Phase I trials in subjects with stable Schizophrenia or Schizoaffective Disorder at two clinical research sites in the period from 2009 to 2014 (Krefetz et al, 2015) The analysis showed that shortening the length of the inpatient period, increasing the outpatient period, and shortening the longest period between outpatient visits had a positive impact on completion.
Register to download
A Retrospective Analysis of the Effects of Protocol Design on Completion Rates in Outpatient Clinical Trials in Subjects with Schizophrenia or Schizoaffective Disorder
You may also be interested in:

Collaboration in Neonatal Study Addresses and Resolves Multi-Stage Difficulties
PRA’s project team turned around a challenging neonatal seizure study to enable successful recruitment. The relationships between the sponsor and the…

Human Abuse Liability Studies: Not Your Traditional Phase I Study
Abuse potential refers to the likelihood for a drug to be used in nonmedical situations for its positive psychoactive effects. PRA Health Sciences’…

CSF Sampling
PRA understands how cerebrospinal fluid (CSF) sampling benefits our clients’ early phase trials. We regularly conduct CSF sampling to collect key PK…